Aktuelles: Frakturprävention: Raloxifen und Knochenqualität

Aktuelles: Frakturprävention: Raloxifen und Knochenqualität

Bibliographic Details
Main Author:	Hasenöhrl N
Format:	Article
Language:	deu
Published:	Krause & Pachernegg GMBH 2013-01-01
Series:	Journal für Gynäkologische Endokrinologie
Subjects:	Fraktur Knochendichte Osteoporose Raloxifen SERM
Online Access:	http://www.kup.at/kup/pdf/11390.pdf

Similar Items

Isoflavone und Soja haben keine Wirkung auf die Knochendichte
by: Burckhardt P
Published: (2013-01-01)

First to know
by: Stute P
Published: (2016-01-01)

Therapieentscheidung bei Osteoporose nach WHO-FRAX und DVO-Algorithmus
by: Rendl, Susanne
Published: (2013)

Chemoprevention of Breast Cancer: The Paradox of Evidence versus Advocacy Inaction
by: Rakhshanda Layeequr Rahman, et al.
Published: (2012-10-01)

Platz der Östrogene in der Primärprävention der Osteoporose
by: Birkhäuser M
Published: (2011-01-01)

Einfluss der Ganzkörpervibration in Kombination mit Östrogen und Raloxifen auf die Skelettmuskulatur der ovarektomierten Ratte
by: Schiefer, Sabine
Published: (2018)

The effect of smoking on the response to raloxifene treatment in postmenopausal osteoporosis
by: Savaş Erdem, et al.
Published: (2012-12-01)

The comparison of effects of alendronate and raloxifene treatment in postmenauposal women with osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2005-12-01)

Comprarison of Risendronate and Raloxifene Treatment in Postmenopausal Osteoporosis - Original Investigation
by: Dilek Koç Yılmaz, et al.
Published: (2006-09-01)

Endometrial hysteroscopic and histological evaluation in menopausal women in continuous use of raloxifene
by: Vanessa Maria Caetano Soares, et al.
Published: (2010-03-01)

Investigation of in vitro and in vivo effects of raloxifene on the pulmonary and systemic vascular circulations.
Published: (2005)

The Comparison of Effects of Alendronate and Raloxifene Treatment in Postmenopausal Women with Osteoporosis - Original Investigation
by: Gülcan Gürer, et al.
Published: (2006-03-01)

A Placebo-Controlled Study of Raloxifene Added to Risperidone in Men with Chronic Schizophrenia
by: Mohammad-Reza Khodaie-Ardakani, et al.
Published: (2015-06-01)

The Pharmacokinetics of Raloxifene and Its Interaction with Apigenin in Rat
by: Ming Hu, et al.
Published: (2010-11-01)

Evalution the Effects of Raloxifene and Risedronate on Serum Biochemical Markers
by: Abdurrahman Yeter, et al.
Published: (2014-12-01)

Massive pulmonary embolism in rheumatoid patient treated with raloxifene: a case report
by: Hala M Haider
Published: (2014-01-01)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
by: Toda A, et al.
Published: (2017-11-01)

6′-Methoxy Raloxifene-analog enhances mouse bone properties with reduced estrogen receptor binding
by: Katherine M. Powell, et al.
Published: (2020-06-01)

Determination of raloxifene hydrochloride in human urine by LC-MS-MS
by: K. Tharpa, et al.
Published: (2009-09-01)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
by: Anuradha Dogiparthi, et al.
Published: (2010-01-01)

Respon Sistem Homeostasis Kalsium Tikus Ovariektomi yang Mengkonsumsi Kombinasi Calcitriol dengan Raloxifene
by: Hartiningsih Hartiningsih, et al.
Published: (2017-02-01)

New treatment paradigm of combined raloxifene and conjugated estrogen for postmenopausal symptoms in VCD-ind
by: Marwa N. Emam, et al.
Published: (2017-08-01)

First Report of Erythema Multiforme Minor Caused by Raloxifene Hydrochloride
by: Yurie Norimatsu, et al.
Published: (2021-09-01)

The Effects of Zoledronate and Raloxifene Combination Therapy on Diseased Mouse Bone
by: Powell, Katherine M.
Published: (2019)

Raloxifene Protects Cisplatin-Induced Renal Injury in Mice via Inhibiting Oxidative Stress
by: An JH, et al.
Published: (2021-09-01)

News-Screen Menopause
by: Frigo P
Published: (2015-01-01)

Managing the risk of invasive breast cancer in women at risk for breast cancer and osteoporosis: the role of raloxifene
by: Victor G Vogel
Published: (2008-12-01)

Effects of Alendronate, Calcitonin and Raloxifene Used in the Treatment of Postmenopausal Osteoporosis On Serum No Levels
by: Saliha Karatay, et al.
Published: (2005-03-01)

LC-UV method to assay raloxifene hydrochloride in rat plasma and its application to a pharmacokinetic study
by: Márcia Camponogara Fontana, et al.

Bone Protective Effects of Danggui Buxue Tang Alone and in Combination With Tamoxifen or Raloxifene in vivo and in vitro
by: Li-Ping Zhou, et al.
Published: (2018-08-01)

Distinct Approaches of Raloxifene: Its Far-Reaching Beneficial Effects Implicating the HO-System
by: Denise Börzsei, et al.
Published: (2020-02-01)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
by: Fujiwara S, et al.
Published: (2014-11-01)

Osteoporose nach Lebertransplantation:Gewicht von Lebergrunderkrankung, Anabolen Sexualhormonen, Immunsuppression sowie Therapie mit Calcitriol als Monotherapeutikum und in Kombination mit Kalzium und Natriumfluorid
by: Kubo, Andreas
Published: (2000)

Ekspresi Tartrate-Resistant Acid Phosphatase-5b pada Epifisis Tulang Femur Tikus Ovariektomi yang Mengkonsumsi Calcitriol dan Raloxifene (TARTRATE-RESISTANT ACID PHOSPHATASE-5b EXPRESSION OF EPIPHYSYS DISTALIS FEMUR OVARIECTOMIZED RATS CONSUMING CALCITRIO
by: Hartiningsih ., et al.
Published: (2016-03-01)

Thermoneutral Housing Did Not Impact the Combined Effects of External Loading and Raloxifene on Bone Morphology and Mechanical Properties in Growing Female Mice
by: Tastad, Carli A.
Published: (2021)

Raloxifene Improves Cognition in Schizophrenia: Spurious Result or Valid Effect?
by: Thomas W. Weickert, et al.
Published: (2017-10-01)

The selective estrogen receptor modulator raloxifene inhibits neutrophil extracellular trap formation.
by: Roxana Flores, et al.
Published: (2016-12-01)

Raloxifene augmentation in men and women with a schizophrenia spectrum disorder: A study protocol
by: Bodyl A. Brand, et al.
Published: (2020-12-01)

Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability
by: Xinhui Du, et al.
Published: (2021-01-01)

Development and Evaluation of Raloxifene-Hydrochloride-Loaded Supersaturatable SMEDDS Containing an Acidifier
by: Jong-Hwa Lee, et al.
Published: (2018-06-01)